Search or choose
Find the right test or package.
CMML Risk Stratification Gene Panel
Chronic Myelomonocytic Leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm, which means it has characteristics of both myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPN). Risk stratification in CMML is important for guiding tre...
DiagnosticsLab test
Know more about this test
Chronic Myelomonocytic Leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm, which means it has characteristics of both myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPN). Risk stratification in CMML is important for g...
Understanding CMML Risk Stratification Gene Panel
Chronic Myelomonocytic Leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm, which means it has characteristics of both myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPN). Risk stratification in CMML is important for guiding treatment decisions and understanding the prognosis of the disease. Next-generation sequencing (NGS) is a powerful tool in the risk stratification of CMML because it allows for the detection of genetic mutations associated with the disease.
What does CMML Risk Stratification Gene Panel measure?
Chronic Myelomonocytic Leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm, which means it has characteristics of both myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPN). Risk stratification in CMML is important for guiding treatment decisions and understanding the prognosis of the disease. Next-generation sequencing (NGS) is a powerful tool in the risk stratification of CMML because it allows for the detection of genetic mutations associated with the disease.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.